iPSC-Derived NK cell (iNK) Iterations and NK Engagers to Target and Kill Solid Tumors

Time: 4:00 pm
day: Day Two

Details:

• Potential of iNK as therapeutics
• Potential role and synergy of NKp46 engagement

Speakers: